NCT04444349 - Protective Effect of CoQ10 Against Negative Inflammatory Response and Organ Dysfunction in Cardiovascular Surgery (PANDA V) | Biotech Hunter

Enrollment

500

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Cardiovascular Disease

Interventions

DRUG

Coenzyme Q10

Coenzyme Q10 is a cardiovascular health supplement. It is a component of the electron transport chain and participates in aerobic cellular respiration, which generates energy in the form of ATP. The ingredients in Coenzyme Q10 help regulate the body's production of free radicals, strengthen the arteries and heart, and reverse oxidation.

DIETARY_SUPPLEMENT

Standard Medical Therapy

Patients only received standard medical therapy without CoQ10.

Trial Locations (4)

210029

RECRUITING

The First Affiliated Hospital of Nanjing Medical University, Nanjing

Unknown

RECRUITING

Beijing Anzhen Hospital, Beijing

RECRUITING

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

RECRUITING

West China Hospital of Sichuan University, Chengdu